Case Presentation: High-Risk, Early-Stage, Triple-Negative Breast Cancer
Medical oncologists, hematologists, gastroenterologists, pulmonologists, internists, surgeons, geneticists, palliative care specialists, basic and translational research scientists, residents, fellows, and medical students need to receive regular updates on advances in the diagnosis and management of hematologic disorders and oncologic/hematologic malignancies and related conditions. The series aims to expand the knowledge base of learners in these topic areas, improve their clinical competencies and research skills, enhance patient care, and improve outcomes.
Physicians, medical students, fellows, residents, and other health professionals.
At the conclusion of the session, the participants should be able to:
- Identify the diagnostic workup of suspected breast cancer.
- Determine when staging scans are indicated for patients with breast cancer.
- Recognize which patients need genetic screening.
- Summarize the neoadjuvant treatment of high risk, triple-negative breast cancer per Keynote 522 study.
- Recall and list immune-related adverse events.
- Discuss the role of monitoring minimal residual disease during surveillance.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Thank you for reviewing this Baylor College of Medicine on-demand activity. In order to complete the evaluation and claim credit for your participation, please select the appropriate payment option above. After payment has been completed, you will receive an email confirmation and receipt.
For any questions, contact firstname.lastname@example.org.